Cascala Health delivers a clinically responsible AI intelligence layer for care teams and post-acute care operators. Its AI-enabled clinical intelligence platform combines AI-powered insights, real-time communication tools, and clinical reasoning, and integrates with any web-based EMR or population health platform to streamline workflows and surface personalized interventions. The company aims to support risk-bearing organizations in delivering better care transitions and ongoing disease management. Cascala has active deployments with early customers, orchestrating care for more than 300,000 patients across thousands of post-acute transitions and empowering over 3,000 primary-care clinicians to engage in patients’ post-acute journeys. Led by CEO and co-founder Matt A. Murphy, the company was launched in mid 2024 and has raised $11.23M to date. The $8.6M seed financing will be used to accelerate product development, expand clinical intelligence capabilities, and grow its customer implementation team.

Total raised

$9M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2025